SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells announced all-stock acquisition of Lumentum to expand its AI data-center optics business is driving attention. Traders are split between viewing the strategic fit and expected synergies as positive long term and worrying that the deals size, dilution, and valuation could weigh on existing shareholders.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells announced all-stock agreement to acquire Lumentum has put the exchange terms at the center of discussion: holders receive a fixed 4.5 Marvell shares per Lumentum share, so the implied value moves with Marvells stock rather than being a guaranteed cash price. Many traders are frustrated that Lumentum is falling despite the headline premium, citing deal-value uncertainty and dilution concerns, while others see strategic value in combining Marvells connectivity products with Lumentums optical technology for AI data centers.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Buzz centers on reports that POETs optical engine appeared in Foxconns photonics ecosystem at Hon Hai Tech Day, which traders view as a credibility signal for the existing FIT collaboration. The community is split on whether the display points to commercial progress or is only a demo, with skeptics looking for purchase orders and shipment evidence; the CFO transition and anticipation of earnings updates are also in the conversation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high is drawing attention ahead of its Q3 report, with traders focused on BRIUMVIs sales momentum and speculating about a buyout or short squeeze. Others caution that the M&A talk is unconfirmed and are watching sales, guidance, and subcutaneous BRIUMVI developments instead.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsomes Q3 results beat expectations and showed strong commercial growth, but the company gave no quantified financial guidance. Traders are divided over the muted share-price reaction: bulls emphasize the growth and potential path to cash-flow break-even, while skeptics point to elevated costs and uncertainty about when profitability will arrive.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned bond sale to finance its AI data-center buildout has renewed concerns about debt and heavy capital spending. Some traders say the borrowing was expected under the companys funding plan, while others question whether future cloud growth will justify the financing burden; a broader tech selloff has added pressure.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment has put pressure on Precigens PAPZIMEOS thesis, prompting debate over whether the rivals dosing profile will take share or whether PAPZIMEOS can retain an advantage through its commercial head start, full approval, and existing market access. Traders are also watching Precigens upcoming earnings for evidence of continued product demand.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

AAOI is caught in a sharp selloff across AI and optical stocks as traders reassess AI infrastructure spending and funding risks, despite no clear company-specific negative news cited. The community is split between dip buyers focused on data-center demand and upcoming earnings, and bears concerned about dilution, customer concentration, and further downside.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

CIFR is drawing attention after a weak Q3 earnings report missed expectations, despite recording its first high-performance computing lease revenue as it shifts from Bitcoin mining toward AI data centers. Traders are split between concern over the results, financing and execution risks, and optimism about contracted leases and the companys longer-term AI infrastructure business.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas preliminary warning that DefenCath reimbursement could decline through 2027 has intensified concerns about the drugs pricing and commercial growth, contributing to a sharp selloff. Traders disagree over whether the warning is a meaningful demand risk or uncertain early modeling, while others point to CMS reimbursement and question how DefenCath will compete with ClearGuard.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


emersalacademy

Anne Dylan